GlassScriptPhysician profile
Robert V Sanders, III
NPI 1881616092
$1,430.77
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $615 · 2021: $213 · 2023: $26.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $314.30 | 2019-2021 | |
| Glaxosmithkline, LLC. | $269.80 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $221.54 | 2019-2021 | |
| Astellas Pharma US INC | $81.72 | 2019-2020 | |
| Novo Nordisk INC | $71.98 | 2019-2020 | |
| Genentech USA, INC. | $71.68 | 2019-2021 | |
| Amarin Pharma, INC. | $62.26 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $40.63 | 2019-2020 | |
| Pfizer INC. | $38.42 | 2020 | |
| Mylan Specialty L.P. | $31.03 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $30.04 | 2021 | |
| Sanofi Pasteur INC. | $26.90 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $16.54 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.02 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $15.81 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.79 | 2019 | |
| Grifols USA, LLC | $15.71 | 2019 | |
| Allergan, INC. | $15.17 | 2020 | |
| Merck Sharp & Dohme LLC | $14.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.